Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Johnson & Johnson zieht die Reißleine - Genmab-Aktie bricht ein

Die Zusammenarbeit zwischen dem US-Pharmazie- und Konsumgüterhersteller Johnson & Johnson und dem dänischen Onkologie-Spezialisten Genmab ist vor allem bei der…

Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson

Coca-Cola, Philip Morris and Johnson & Johnson are part of the Zacks Investment Ideas article.…

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson

Gilead Sciences and Johnson & Johnson are part of the Zacks Investment Ideas article.…

3 ETFs to Buy Now for Passive Dividend Income

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) down on…

Pfizer Vs. Johnson & Johnson: Whos The Better Bargain For Investors

…

Kenvue settles proxy fight with activist Starboard, adding three directors to its board

Starboards Jeff Smith will join the board of the Johnson & Johnson spinoff.…

Buy Johnson & Johnson (JNJ) Stock for Higher Highs?

Amid recent market volatility, Johnson & Johnson (JNJ) stock hit new 52-week highs of nearly $170 on Tuesday.…

Why the Market Dipped But Johnson & Johnson (JNJ) Gained Today

Johnson & Johnson (JNJ) reachead $167.28 at the closing of the latest trading day, reflecting a +1.37% change compared to…

3 Dividend Stocks That Are No-Brainer Buys Right Now

It can be difficult to decide which dividend stocks to buy. After all, more than 5,700 of them trade on…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $166.09, denoting a +1.44% change from…

J&J sues Samsung Bioepis over contract breach for Stelara biosimilar

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with…

Healthcare sector leads S&P 500 YTD, Johnson & Johnson and Gilead show promise

Healthcare sector leads S&P 500 YTD, Johnson & Johnson and Gilead show promise - BTIG…

Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Johnson Johnson: Die Marken des Unternehmens

Johnson Johnson steht - ähnlich wie auch andere Grosskonzerne - hinter vielen Marken, von denen Kunden oft gar nicht…

Johnson & Johnson (JNJ) Laps the Stock Market: Heres Why

The latest trading day saw Johnson & Johnson (JNJ) settling at $157.89, representing a +1.87% change from its previous close.…

Johnson & Johnson: Rich History Of Excellence Poised To Endure

…

Dividenden-Aristokrat Johnson & Johnson: Sparten-Verkauf geplant

Der amerikanische Pharmazie- und Konsumgüterhersteller Johnson & Johnson will sich laut einem Bericht der Financial Times (FT) von seinem Schlaganfall-Geschäft…

Dividenden-Aristokrat Johnson & Johnson: Sparten-Verkauf geplant

Der amerikanische Pharmazie- und Konsumgüterhersteller Johnson & Johnson will sich laut einem Bericht der Financial Times (FT) von seinem Schlaganfall-Geschäft…

Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times By Investing.com

Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times…

Johnson & Johnson Aktie: Verkauf des Schlaganfall-Geschäfts geplant

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Solvonis Therapeutics: A new player in the $450bn “neuro-psych” sector

In the world of life sciences, deal flow often serves as a barometer for emerging trends. The recent acquisitions by…

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

The Zacks Analyst Blog Highlights NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern

NVIDIA, Johnson & Johnson, T-Mobile US and The Eastern are included in this Analyst Blog.…

Is Johnson & Johnson Stock a Buy?

Johnson & Johnson (NYSE: JNJ) is one of the worlds largest and most prominent healthcare leaders. If investing in a…

Johnson & Johnson Aktie: Kursziel gesteigert

London (www.aktiencheck.de) - Rating-Update: Die Empfehlung von Barclays für die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046, WKN: 853260, Ticker-Symbol:…

Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

Todays Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & Johnson (JNJ) and…

US government could seek over $1 billion from J&J for cancer treatment costs

The U.S. Department of Health & Human Services may seek over $1 billion from Johnson & Johnson as reimbursement for…

Top Research Reports for NVIDIA, Johnson & Johnson and T-Mobile

Todays Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Johnson & Johnson (JNJ) and…

Spravato sales growth highlights commercial viability of psychedelics, analysts believe

The latest quarterly sales figures for Johnson & Johnson (NYSE:JNJ)’s esketamine nasal spray support the notion that psychedelics can become…

Johnson & Johnson Aktie: Kursziel reduziert

New York (www.aktiencheck.de) - Rating-Update: Sanford C. Bernstein hat das Kursziel für die Aktie von Johnson & Johnson (J&J) (ISIN: US4781601046,…

Johnson & Johnson Aktie: Kursziel gekürzt

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Morgan Stanley haben das Kursziel für Johnson & Johnson (ISIN: US4781601046, WKN: 853260,…

Johnson & Johnson Aktie: Kursziel gesenkt

Charlotte (www.aktiencheck.de) - Rating-Update: Die Analysten von BofA Securities bekräftigen das "neutral"-Rating für die Aktie von Johnson & Johnson (J&J) (ISIN:…

Johnson & Johnson Aktie: Kurzfristiges Aufwärtspotenzial begrenzt

St. Louis (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Stifel: Der Stifel-Analyst Rick Wise hat das Kursziel für die Aktie von Johnson…

Johnson & Johnson übertrifft Prognosen, Aktienkurs fällt zunächst, erholt sich dann wieder

Frankfurt (www.aktiencheck.de) - Johnson & Johnson übertrifft Prognosen, Aktienkurs fällt zunächst, erholt sich dann wieder - Aktiennews Johnson & Johnson (ISIN:…

S&P 500 hits intraday high, boosted by Netflix, AI investment plan

STORY: Wall Streets main indexes rose Wednesday, with the S&P 500 hitting an intraday record high thanks to strong Netflix…

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript

JNJ earnings call for the period ending December 31, 2024.…

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript

…

Stocks making the biggest midday moves: Netflix, Johnson & Johnson, Oracle, Ford and more

These are some of the the stocks posting the largest moves in midday trading.…

Johnson & Johnson Aktie: Dividenden-Aristokrat überzeugt

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Jürgen Dreifürst vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die…

Johnson & Johnson Tops Q4 EPS Forecasts

Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.…

Gutes Geschäft mit Krebsmedikamenten verleiht Johnson & Johnson Schub

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im vergangenen Jahr die Umsatzeinbußen bei einem seiner wichtigsten…

Johnson & Johnson: Dividenden-Aristokrat überzeugt

In einem dynamischen Gesundheitsmarkt, der von technologischen Innovationen und steigenden Gesundheitsausgaben geprägt ist, hat Johnson & Johnson seine Widerstandsfähigkeit und…

Johnson & Johnson: Dividenden-Aristokrat überzeugt

In einem dynamischen Gesundheitsmarkt, der von technologischen Innovationen und steigenden Gesundheitsausgaben geprägt ist, hat Johnson & Johnson seine Widerstandsfähigkeit und…

J&J beats quarterly sales and profit estimates on cancer drug sales

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter sales and…

Johnson & Johnson slides as soft sales guidance casts shadow

Johnson & Johnson shares faced pressure on Wednesday as soft sales guidance for the coming year cast a shadow over…

Johnson & Johnson Aktie: Fokus auf makroökonomische Faktoren

London (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von Barclays: Rating und Kursziel Barclays hat das Kursziel für die Aktie von Johnson & Johnson…

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health Care…